Webinar
March 19, 2024 at 1:00 PM EST

Manufacturer portfolios are becoming more diversified in terms of product archetypes. Outside of traditional retail brands, traditional syndicated data sources are losing coverage and accuracy as a demand source. 867 data that is carefully stewarded and unblinded can fill enormous gaps for vaccines, specialty lite, specialty HCP admin, bio similars, and specialty generics. In this session, we will discuss different use cases, key stakeholders, and business benefits of enriched 867 data.

Join Emily Mortimer and  Samer Allabadi on March 19 to learn more!

Emily Mortimer
Executive Director, Customer Operations

Samer Allabadi
Senior Director, Channel and Patient Advisory